Vivo Bio tech Ltd.

Web: vivobio.com NSE: VIVOBIOT BSE: 511509 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

19 0(2%)

Near 52W Low of 18

Volume

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

5/100

Growth Score

71/100

Valuation Score

50/100

Momentum Score

0/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

No. of Shares

2.22

P/E

7.82

P/B

1.08

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

13.81

ROCE

Profit Growth

Listing Date

Promoter Holding

35.43%

FII Holding

DII Holding

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Apr 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.31) 35.43%	(0.01) 35.17%	(-3.91) 35.17%	(-4.31) 39.07%	(2.51) 43.35%	(2.01) 40.85%	(-3.21) 38.89%	(0.01) 42.08%	(0.01) 42.08%	(0.01) 42.08%	(0.01) 42.08%	(0.01) 42.08%	(0.01) 42.08%	(-0.11) 42.08%	(0.01) 42.16%	(0.01) 42.16%	(2.51) 42.16%	(-0.21) 39.67%	(0.01) 39.84%
Public	64.58%	64.84%	64.84%	60.94%	56.65%	59.16%	61.12%	57.91%	57.92%	57.92%	57.92%	57.91%	57.92%	57.91%	57.84%	57.83%	57.84%	60.33%	60.16%
No. of Shareholders	21,427	21,622	21,647	21,865	21,935	21,935	21,167	19,545	18,852	18,971	15,615	13,006	12,989	13,062	13,048	13,036	12,632	12,455	11,364

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Sales	14.28	14.2	13.51	13.11	12.51	12.29	12.21	12.04	10.13	11.76	12.85	9.26	11.58	14.76	13.54	12.67	11.26	15.31	12.92	10.17
Sales Growth % (YoY)	14.2%	15.5%	10.6%	8.9%	23.5%	4.5%	-5%	30%	-12.5%	-20.3%	-5.1%	-26.9%	2.8%	-3.6%	4.8%	24.6%	-13.4%	-4.8%	8.8%	-30.7%
Sales Growth % (QoQ)	0.6%	5.1%	3.1%	4.8%	1.8%	0.7%	1.4%	18.9%	-13.9%	-8.5%	38.8%	-20%	-21.5%	9%	6.9%	12.5%	-26.5%	18.5%	27%	-
Expenses	9.23	9.75	8.02	7.69	7.03	7.27	6.67	6.45	5.77	6.39	6.48	4.4	7.09	7.63	8.62	8.01	6.48	13.7	7.17	6.34
Operating Profit	5.05	4.45	5.49	5.42	5.48	5.02	5.54	5.59	4.36	5.37	6.37	4.86	4.49	7.13	4.92	4.66	4.78	1.61	5.75	3.83
OPM %	35.36	31.34	40.64	41.34	43.8	40.85	45.37	46.43	43.04	45.66	49.57	52.48	38.77	48.31	36.34	36.78	42.45	10.52	44.5	37.66
Other Income	0.06	0.03	0.14	0.13	0.14	0.15	0.01	4.63	0.01	0.01	0.03	0	0	0.02	0.01	0.01	0	-0.15	0	0.03
Interest	1.24	1.48	1.4	1.47	1.5	1.68	1.84	2.06	1.92	1.52	2.22	2.09	1.95	2.01	2.08	1.79	1.76	0.87	1.2	1.06
Depreciation	3.53	2.75	2.66	2.57	2.64	2.25	2.25	2.29	2.23	2.43	2.28	2.3	2.29	2.26	2.3	2.37	2.33	2.21	1.71	1.74
Profit before tax	0.34	0.25	1.57	1.51	1.48	1.24	1.46	5.87	0.22	1.43	1.9	0.47	0.25	2.88	0.55	0.51	0.69	-1.62	2.84	1.06
Tax %	44.12	2164	20.38	42.38	9.46	14.52	43.84	10.73	27.27	48.95	31.05	29.79	44	28.47	72.73	78.43	53.62	-58.02	51.76	74.53
Net Profit	0.19	-5.16	1.25	0.87	1.34	1.06	0.82	5.23	0.17	0.74	1.32	0.33	0.14	2.06	0.15	0.12	0.32	-0.69	1.37	0.28
Net Profit Growth % (QoQ)	103.7%	-512.8%	43.7%	-35.1%	26.4%	29.3%	-84.3%	2976.5%	-77%	-43.9%	300%	135.7%	-93.2%	1273.3%	25%	-62.5%	146.4%	-150.4%	389.3%	-
Net Profit Growth % (YoY)	-85.8%	-586.8%	52.4%	-83.4%	688.2%	43.2%	-37.9%	1484.8%	21.4%	-64.1%	780%	175%	-56.2%	398.6%	-89.1%	-57.1%	-	-	-	-
TTM Net Profit	-2.85	-1.7	4.52	4.09	8.45	7.28	6.96	7.46	2.56	2.53	3.85	2.68	2.47	2.65	-0.1	1.12	1.28	0.96	1.65	0
EPS in Rs	0.09	-2.33	0.57	0.39	0.67	0.62	0.51	3.51	0.11	0.5	0.89	0.22	0.09	1.38	0.1	0.08	0.22	-0.48	0.96	0.2

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	53.33	46.67	45.45	52.23	51.39	51.78	55.35	55.83	47	34.13	28.58	17.79	16.13	14.37
Sales Growth %	14.3%	2.7%	-13%	1.6%	-0.8%	-6.4%	-0.9%	18.8%	37.7%	19.4%	60.6%	10.3%	12.2%	15.1%
Expenses	32.48	26.11	24.19	30.39	35.3	33.98	42.88	46.32	36.11	26.51	24.87	14.99	14.38	12.01
Operating Profit	20.85	20.56	21.26	21.84	16.09	17.8	12.47	9.51	10.89	7.62	3.71	2.8	1.75	2.36
OPM %	39.1	44.05	46.78	41.82	31.31	34.38	22.53	17.03	23.17	22.33	12.98	15.74	10.85	16.42
Other Income	0.44	4.8	0.04	0.04	0.1	0.08	0.05	0.01	0.13	0.4	0.89	0.95	0.88	0.76
Interest	5.85	7.55	7.95	7.99	4.27	3.67	3.1	2.64	2.37	1.29	0.47	0.51	0.39	0.78
Depreciation	10.63	9.02	9.29	9.27	7.45	5.59	5.17	5.06	4.64	3.9	3.35	3.05	1.56	1.57
Profit before tax	4.81	8.79	4.06	4.62	4.47	8.62	4.25	1.82	4.01	2.83	0.78	0.19	0.68	0.77
Tax %	135.55	17.18	37.93	42.64	50.78	34.11	-4.47	-23.08	21.95	11.66	-16.67	-142.11	55.88	49.35
Net Profit	-1.71	7.28	2.53	2.65	2.2	5.68	4.44	2.25	3.12	2.5	0.91	0.46	0.29	0.39
Net Profit Growth %	-123.5%	187.7%	-4.5%	20.5%	-61.3%	27.9%	97.3%	-27.9%	24.8%	174.7%	97.8%	58.6%	-25.6%	-
EPS in Rs	-0.77	4.24	1.7	1.78	1.54	4.23	3.45	1.82	3.17	2.67	0.97	0.49	0.31	0.42
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	11.83	15.52	14.83	16.64	14.18	8.61	-0.78	11.11	-5.66	8.81	2.25	2.79	2.12
Cash from Investing Activity	-15.84	-7.95	-4	-51.11	-22.82	-10.23	-3.53	-4.72	-11.84	-7.2	-2.04	-1.42	25.03
Cash from Financing Activity	3.9	-7.56	-11.18	35.02	8.78	2.09	0.72	-3.43	6.83	-0.32	-0.89	-0.44	-19.33
Net Cash Flow	-0.11	0.01	-0.34	0.55	0.14	0.47	-3.59	2.96	-10.67	1.3	-0.68	0.93	7.82

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	22.19	22.1	17.16	14.9	14.9	14.9	14.26	13.42	12.89	12.35	9.85	9.35	9.35	9.35	9.35	9.35
Reserves	70.97	74.67	60.74	44.9	39.5	36.97	32.87	29.11	20.14	14.92	9.46	3.22	0.71	-0.18	-0.83	-1.12
Borrowings	67.38	56.53	54.03	57.89	73.06	62.39	67.44	30.96	24.37	21.68	25.12	27.06	16.91	5.69	6.62	3.58
Other Liabilities	17.89	11.88	11.3	10.23	9.67	8.77	7.91	6.03	6.29	6.37	15.08	11.49	18.69	26.57	24.9	26.86
Total Liabilities	178.43	165.18	143.23	127.92	137.13	123.03	122.48	79.52	63.69	55.32	59.51	51.12	45.66	41.43	40.04	38.67
Fixed Assets	123.02	83.16	88.24	74.26	80.37	88.87	95.17	52.05	34.99	30.01	27.66	28.57	23.54	19.69	20.59	20.73
CWIP	4.81	12.86	12.84	11.3	9.21	1.9	0.87	0.32	0.15	0.07	3.94	2.96	0.04	0.07	0	0
Investments	21.91	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	28.69	69.16	42.15	42.36	47.55	32.26	26.44	27.15	28.55	25.24	27.91	19.59	22.08	21.67	19.45	17.94
Total Assets	178.43	165.18	143.23	127.92	137.13	123.03	122.48	79.52	63.69	55.32	59.51	51.12	45.66	41.43	40.04	38.67

Delivery

Delivery Data: VIVOBIOT

#	Date	18 20% 21	Q/T 162	Del 87
1	4-Sep	19	113	84
2	3-Sep	19	109	93
3	2-Sep	18	65	82
4	1-Sep	18	149	74
5	31-Aug	19	107	88
6	28-Aug	18	126	93
7	27-Aug	19	253	90
8	26-Aug	18	118	92
9	25-Aug	19	127	91
10	24-Aug	19	188	83
11	21-Aug	19	118	77
12	20-Aug	19	279	82
13	19-Aug	19	45	100
14	18-Aug	19	139	97
15	17-Aug	20	132	82

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	42c	100L	2.42
03-Sep	41c	36L	0.85
01-Sep	42c	60L	1.46
31-Aug	41c	1c	2.48
26-Aug	42c	20L	0.48
25-Aug	42c	60L	1.45
24-Aug	41c	98L	2.31
21-Aug	42c	2L	0.05
19-Aug	42c	27L	0.63
18-Aug	43c	1c	2.79
17-Aug	44c	0	0

Stock Checklist

Price is above from 52 week high low average: 44%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: YES

Mutual Fund Holdings

No mutual fund holding data available.

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView